CERo Therapeutics Holdings, Inc.

CERO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 7, 2026 CURRENT REPORT
8-K Aug 31, 2026 CURRENT REPORT
424B3 Aug 14, 2026 PROSPECTUS SUPPLEMENT
10-Q Aug 14, 2026 QUARTERLY REPORT
SCHEDULE 13G/A Aug 14, 2026
424B3 Jul 17, 2026 PROSPECTUS SUPPLEMENT
8-K Jul 17, 2026 CURRENT REPORT
25-NSE Jul 13, 2026
424B3 Jun 26, 2026 PROSPECTUS SUPPLEMENT
8-K Jun 26, 2026 CURRENT REPORT
424B3 May 29, 2026 PROSPECTUS SUPPLEMENT
8-K May 29, 2026 CURRENT REPORT
424B3 May 15, 2026 PROSPECTUS SUPPLEMENT
10-Q May 15, 2026 QUARTERLY REPORT
424B3 May 1, 2026 PROSPECTUS SUPPLEMENT
8-K May 1, 2026 CURRENT REPORT
424B3 May 1, 2026 PROSPECTUS SUPPLEMENT
10-K/A Apr 30, 2026 AMENDMENT NO. 1 TO FORM 10-K
4 Apr 21, 2026
3 Apr 21, 2026
424B3 Apr 15, 2026 PROSPECTUS SUPPLEMENT NO. 8
10-K Apr 15, 2026 ANNUAL REPORT
424B3 Apr 14, 2026 PROSPECTUS SUPPLEMENT
8-K Apr 14, 2026 CURRENT REPORT
NT 10-K Apr 1, 2026 NOTIFICATION OF LATE FILING
← Newer Page 1 of 18 · 445 filings Older →